Fixed dose combination Ciprofloxacin/Celecoxib
NST001
Phase 1 small_molecule completed
Quick answer
Fixed dose combination Ciprofloxacin/Celecoxib for ALS (Amyotrophic Lateral Sclerosis) is a Phase 1 program (small_molecule) at NeuroSense Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NeuroSense Therapeutics
- Indication
- ALS (Amyotrophic Lateral Sclerosis)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed